Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2026-01-06 @ 7:33 PM
Study NCT ID:
NCT02858258
Status:
RECRUITING
Last Update Posted:
2017-12-19
First Post:
2016-07-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ASCT After a Rituximab/Ibrutinib/Ara-c Containing iNduction in Generalized Mantle Cell Lymphoma
Sponsor:
Prof. Dr. M. Dreyling (co-chairman)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-07
Start Date Type:
None
Primary Completion Date:
2021-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-05
Completion Date Type:
ESTIMATED
First Submit Date:
2016-07-14
First Submit QC Date:
None
Study First Post Date:
2016-08-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-12-17
Last Update Post Date:
2017-12-19
Last Update Post Date Type:
ACTUAL